Skip to main content
OpenTrials
Completed

NCT Number: NCT06143033

A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area

This study will evaluate the efficacy of the DIME Beauty Luminosity Eye Serum in improving the appearance of skin in the periorbital eye area. This study will last for 60 days. The study will be conducted as a single-arm trial in which all participants will use the test products. Participants will be required to complete questionnaires at Baseline, Day 30, and Day 60, photos will be taken at Baseline, Day 30, and Day 60, and expert skin grading will take place at Baseline and Day 60.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Periorbital Area

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 90404, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females age 18-65.
  • Have visible dark circles under the eyes.
  • Have puffy eyes.
  • Have bags under the eyes.
  • Have visible fine lines and wrinkles around the eyes.
  • Have a smartphone or camera to take before-and-after selfies.

Exclusion criteria

  • Anyone not in good health.
  • Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
  • Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
  • Anyone who is pregnant, breastfeeding, or wanting to become pregnant over the next three months.
  • Anyone who cannot/ will not commit to the study protocol.
  • Anyone with a history of substance abuse.

Treatment and study plan

DIME Beauty Luminosity Eye Serum

Other

Test product contains: Water/Aqua, Organic Aloe Vera Juice, Lycium Barbarum (Goji Berry) Fruit Extract, Vitis Vinifera (Grape Seed) Extract, Cucumis Sativus (Cucumber) Extract, Glycerin, Niacinamide, Squalane, Camellia Seed Oil, DL-Panthenol (Vitamin B5), Carbomer, Sodium Hyaluronate, Ammonium Acryloyldimethyltaurate/VP Copolymer, Phenoxyethenol, Caprylyl Glycol, Acacia Senegal Gum, Caffeine, Helianthus Annuus (Sunflower) Seed Oil, Malus Domestica (Apple) Fruit Stem Cell Extract, Argania Spinosa (Argan) Sprout Stem Cell Extract, Tetrahexyldecyl Ascorbate (Vitamin C), Acetyl Tetrapeptide, Acetyl Hexapeptide-8, Vitamin E Mixed Tocopherols, Sodium Hydroxide.

Primary outcomes

  1. Change in appearance of periorbital puffiness. [Baseline to Day 60]

    Time frame: 60 days

    Measured via expert skin grading of before & after photos conducted by a board-certified dermatologist.

  2. Change in appearance of dark circles underneath eyes. [Baseline to Day 60]

    Time frame: 60 days

    Measured via expert skin grading of before & after photos conducted by a board-certified dermatologist.

  3. Change in participants' perception of the appearance of periorbital puffiness. [Baseline to Day 60]

    Time frame: 60 days

    Measured via study-specific surveys. Surveys will be completed by participants and are designed using a 5-point Likert scale, with th 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

  4. Change in participants' perception of the appearance of dark circles underneath eyes. [Baseline to Day 60]

    Time frame: 60 days

    Measured via study-specific surveys. Surveys will be completed by participants and are designed using a 5-point Likert scale, with th 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

Secondary outcomes

  1. Change in appearance of fine lines and wrinkles in the eye area. [Baseline to Day 60]

    Time frame: 60 days

    Measured via expert skin grading of before & after photos conducted by a board-certified dermatologist.

  2. Change in participants' perception of the appearance of fine lines and wrinkles in the eye area. [Baseline to Day 60]

    Time frame: 60 days

    Measured via study-specific surveys. Surveys will be completed by participants and are designed using a 5-point Likert scale, with th 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

Sponsors and collaborators

Lead sponsor

Dime Beauty Co.

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 22, 2023
Registry last updated
Feb 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.